Mesenchymal stem cells (MSCs) and their stromal progeny may be considered powerful regulatory cells, a sort of dendritic cell counterpart, which influence all the main immune effectors and functional roles in vivo, as well as potential applications in the treatment of a number of human immunological diseases. By choosing MSC tissue origin, cell dose, administration route, and treatment schedule, all the potential side effects related to MSC use, including tumor growth enhancement, have to be well considered to maximize the benefits of MSC-dependent immune regulation without significant risks for the patients.
Immune modulation by mesenchymal stem cells / F. Bifari, V. Lisi, E. Mimiola, A. Pasini, M. Krampera. - In: TRANSFUSION MEDICINE AND HEMOTHERAPY. - ISSN 1660-3796. - 35:3(2008), pp. 194-204. [10.1159/000128968]
Immune modulation by mesenchymal stem cells
F. BifariPrimo
;
2008
Abstract
Mesenchymal stem cells (MSCs) and their stromal progeny may be considered powerful regulatory cells, a sort of dendritic cell counterpart, which influence all the main immune effectors and functional roles in vivo, as well as potential applications in the treatment of a number of human immunological diseases. By choosing MSC tissue origin, cell dose, administration route, and treatment schedule, all the potential side effects related to MSC use, including tumor growth enhancement, have to be well considered to maximize the benefits of MSC-dependent immune regulation without significant risks for the patients.File | Dimensione | Formato | |
---|---|---|---|
128968.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
494.25 kB
Formato
Adobe PDF
|
494.25 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.